Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial

BACKGROUND: Angiotensin-converting enzyme inhibitors improve outcomes in systolic heart failure (SHF). However, doubts linger about their effect in SHF patients with chronic kidney disease (CKD). METHODS: In the Studies of Left Ventricular Dysfunction (SOLVD) Treatment trial, 2569 ambulatory chronic...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Bowling, C. Barrett, Sanders, Paul W., Allman, Richard M., Rogers, William J., Patel, Kanan, Aban, Inmaculada B., Rich, Michael W., Pitt, Bertram, White, Michel, Bakris, George C., Fonarow, Gregg C., Ahmed, Ali
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2012
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395757/
https://ncbi.nlm.nih.gov/pubmed/22257685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2011.12.056
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια